BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12530558)

  • 1. Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor alpha-deficient mice.
    Guillou H; Martin P; Jan S; D'Andrea S; Roulet A; Catheline D; Rioux V; Pineau T; Legrand P
    Lipids; 2002 Oct; 37(10):981-9. PubMed ID: 12530558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
    Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha is not the exclusive mediator of the effects of dietary cyclic FA in mice.
    Bretillon L; Alexson SE; Joffre F; Pasquis B; Sébédio JL
    Lipids; 2003 Sep; 38(9):957-63. PubMed ID: 14584603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of liver X receptor, insulin and peroxisome proliferator activated receptor alpha on in vivo desaturase modulation of unsaturated fatty acid biosynthesis.
    Montanaro MA; González MS; Bernasconi AM; Brenner RR
    Lipids; 2007 Apr; 42(3):197-210. PubMed ID: 17393226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
    Peters JM; Hennuyer N; Staels B; Fruchart JC; Fievet C; Gonzalez FJ; Auwerx J
    J Biol Chem; 1997 Oct; 272(43):27307-12. PubMed ID: 9341179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
    Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
    J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha.
    Matsuzaka T; Shimano H; Yahagi N; Amemiya-Kudo M; Yoshikawa T; Hasty AH; Tamura Y; Osuga J; Okazaki H; Iizuka Y; Takahashi A; Sone H; Gotoda T; Ishibashi S; Yamada N
    J Lipid Res; 2002 Jan; 43(1):107-14. PubMed ID: 11792729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway.
    Edgar AD; Tomkiewicz C; Costet P; Legendre C; Aggerbeck M; Bouguet J; Staels B; Guyomard C; Pineau T; Barouki R
    Toxicol Lett; 1998 Sep; 98(1-2):13-23. PubMed ID: 9776557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice.
    Peters JM; Park Y; Gonzalez FJ; Pariza MW
    Biochim Biophys Acta; 2001 Oct; 1533(3):233-42. PubMed ID: 11731333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.
    Jeong S; Han M; Lee H; Kim M; Kim J; Nicol CJ; Kim BH; Choi JH; Nam KH; Oh GT; Yoon M
    Metabolism; 2004 Oct; 53(10):1284-9. PubMed ID: 15375783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype of peroxisome proliferator-activated receptor-alpha(PPARalpha)deficient mice on mixed background fed high fat diet.
    Kim BH; Won YS; Kim EY; Yoon M; Nam KT; Oh GT; Kim DY
    J Vet Sci; 2003 Dec; 4(3):239-44. PubMed ID: 14685029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.
    DeLuca JG; Doebber TW; Kelly LJ; Kemp RK; Molon-Noblot S; Sahoo SP; Ventre J; Wu MS; Peters JM; Gonzalez FJ; Moller DE
    Mol Pharmacol; 2000 Sep; 58(3):470-6. PubMed ID: 10953038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.
    Thomas J; Bramlett KS; Montrose C; Foxworthy P; Eacho PI; McCann D; Cao G; Kiefer A; McCowan J; Yu KL; Grese T; Chin WW; Burris TP; Michael LF
    J Biol Chem; 2003 Jan; 278(4):2403-10. PubMed ID: 12441342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.
    Inoue H; Jiang XF; Katayama T; Osada S; Umesono K; Namura S
    Neurosci Lett; 2003 Dec; 352(3):203-6. PubMed ID: 14625020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate, a ligand for PPARalpha, inhibits aromatase cytochrome P450 expression in the ovary of mouse.
    Toda K; Okada T; Miyaura C; Saibara T
    J Lipid Res; 2003 Feb; 44(2):265-70. PubMed ID: 12576508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARalpha-deficient mice.
    Guéraud F; Alary J; Costet P; Debrauwer L; Dolo L; Pineau T; Paris A
    J Lipid Res; 1999 Jan; 40(1):152-9. PubMed ID: 9869661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.
    Duez H; Chao YS; Hernandez M; Torpier G; Poulain P; Mundt S; Mallat Z; Teissier E; Burton CA; Tedgui A; Fruchart JC; Fiévet C; Wright SD; Staels B
    J Biol Chem; 2002 Dec; 277(50):48051-7. PubMed ID: 12377786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.